A research-oriented primer on BPC-157: what it is, what the preclinical literature shows, how researchers dose it, and where the evidence actually ends.

A critical breakdown of BPC-157 side effect data, from preclinical findings to the near-total absence of controlled human safety trials.

Tirzepatide vs semaglutide and liraglutide: head-to-head efficacy, safety, cost, and dosing compared. A verdict-first guide for informed buyers.

TB-500 and BPC-157 compared on efficacy, safety, and practical use. See which peptide has stronger evidence for tissue repair and recovery decisions.